Curis (CRIS) FCF Margin (2010 - 2025)

Curis (CRIS) reported FCF Margin of 559.84% for Q4 2025, down 28301.0% on a YoY basis from N/an in Q4 2024, and down 219.28% quarter-over-quarter from 175.35% in Q3 2025.

Curis (CRIS) FCF Margin (2010 - 2025) Analysis & Trends

Curis has reported FCF Margin for 16 years, with the latest figure at 559.84% in Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 28301.0% year-over-year to 559.84%; the trailing twelve-month figure through Mar 2026 stood at 409.87% (down 11007.0% YoY), and the FY2025 full-year result was 288.05%, up 7464.0% from the prior year.
  • FCF Margin for Q4 2025 stood at 559.84%, down from 175.35% in the prior quarter.
  • The five-year high for FCF Margin was 175.35% in Q3 2025, with the low at 817.99% in Q1 2022.
  • Historically, FCF Margin has averaged 406.96% across 5 years, with a median of 367.97% in 2023.
  • The largest YoY upside for FCF Margin was 32962 bps in 2025 against a maximum downside of 28301 bps in 2025.
  • Curis' FCF Margin stood at 260.64% in 2021, then tumbled by 63 bps to 424.94% in 2022, then increased by 11 bps to 377.82% in 2023, then rose by 27 bps to 276.83% in 2024, then tumbled by 102 bps to 559.84% in 2025.
  • The last three FCF Margin figures came in at 559.84% (Q4 2025), 175.35% (Q3 2025), and 291.34% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 43.35%
9 Abivax 95.45 Bn 95.45 Bn - -
10 Curis 8.58 Mn -6.42 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -559.84%
Sep 30, 2025 -175.35%
Jun 30, 2025 -291.34%
Mar 31, 2025 -304.71%
Dec 31, 2024 -276.83%
Sep 30, 2024 -202.52%
Jun 30, 2024 -437.35%
Mar 31, 2024 -634.32%
Dec 31, 2023 -377.82%
Sep 30, 2023 -288.78%
Jun 30, 2023 -358.12%
Mar 31, 2023 -531.08%
Dec 31, 2022 -424.94%
Sep 30, 2022 -466.34%
Jun 30, 2022 -521.73%
Mar 31, 2022 -817.99%
Dec 31, 2021 -260.64%
Sep 30, 2021 -316.22%
Jun 30, 2021 -291.29%
Mar 31, 2021 -602.06%